Adaptive Biotechnologies' Series C Round

Adaptive Biotechnologies raised a round of funding on July 12, 2013.

Adaptive Biotechnologies (NASDAQ: ADPT) focuses on immunosequencing diagnostics, specifically in oncology. The company leverages advances in sequencing to profile T-Cell and B-Cell Receptors. This ena…

Articles about Adaptive Biotechnologies' Series C Round: